Evidence map›Paper›PMID 35616633›Full record

ArticleeLife2022

The LOTUS initiative for open knowledge management in natural products research.

Adriano Rutz, Maria Sorokina, Jakub Galgonek, Daniel Mietchen, Egon Willighagen, Arnaud Gaudry, James G Graham, Ralf Stephan, Roderic Page, Jiří Vondrášek and 5 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 174 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
174citing papers in PubMed, 1 pooled it
63.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

174 citing papers in PubMed, 1 synthesis or guideline pooled it, 385 citations in OpenAlex.

  1. ManagingMolecules (Basel, Switzerland) · 2025
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Green Synthesis Characterization and Evaluation ofMolecules (Basel, Switzerland) · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Rambutan (Molecules (Basel, Switzerland) · 2026
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

114 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 7 countries.

Adriano RutzSchool of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.ORCID 0000-0003-0443-9902
Maria SorokinaInstitute for Inorganic and Analytical Chemistry, Friedrich-Schiller-University Jena, Jena, Germany.ORCID 0000-0001-9359-7149
Jakub GalgonekInstitute of Organic Chemistry and Biochemistry of the CAS, Prague, Czech Republic.ORCID 0000-0002-7038-544X
Daniel MietchenRonin Institute, Montclair, United States.ORCID 0000-0001-9488-1870
Egon WillighagenDepartment of Bioinformatics-BiGCaT, Maastricht University, Maastricht, Netherlands.ORCID 0000-0001-7542-0286
Arnaud GaudrySchool of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.ORCID 0000-0002-3648-7362
James G GrahamCenter for Natural Product Technologies and WHO Collaborating Centre for Traditional Medicine (WHO CC/TRM), Pharmacognosy Institute; College of Pharmacy, University of Illinois at Chicago, Chicago, United States.
Ralf StephanOntario Institute for Cancer Research (OICR), University Ave Suite, Toronto, Canada.ORCID 0000-0002-4650-631X
Roderic PageUniversity of Glasgow, Glasgow, United Kingdom.ORCID 0000-0002-7101-9767
Jiří VondrášekInstitute of Organic Chemistry and Biochemistry of the CAS, Prague, Czech Republic.ORCID 0000-0002-6066-973X
Christoph SteinbeckInstitute for Inorganic and Analytical Chemistry, Friedrich-Schiller-University Jena, Jena, Germany.ORCID 0000-0001-6966-0814
Guido F PauliCenter for Natural Product Technologies and WHO Collaborating Centre for Traditional Medicine (WHO CC/TRM), Pharmacognosy Institute; College of Pharmacy, University of Illinois at Chicago, Chicago, United States.ORCID 0000-0003-1022-4326
Jean-Luc WolfenderSchool of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.ORCID 0000-0002-0125-952X
Jonathan BissonCenter for Natural Product Technologies and WHO Collaborating Centre for Traditional Medicine (WHO CC/TRM), Pharmacognosy Institute; College of Pharmacy, University of Illinois at Chicago, Chicago, United States.ORCID 0000-0003-1640-9989
Pierre-Marie AllardSchool of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.ORCID 0000-0003-3389-2191
University of Geneva · CHUniversity of Illinois Chicago · USCzech Academy of Sciences, Institute of Organic Chemistry and Biochemistry · CZFriedrich Schiller University Jena · DELeibniz Institute of Freshwater Ecology and Inland Fisheries · DEMaastricht University · NLOntario Institute for Cancer Research · CAUniversity of Glasgow · GB

Funding

Van Breemen: Project 3; Botanical Dietary Supplements - Metabolism and Safety in Women (Van Breemen)P50AT000155 · NCCIH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PAULI, GUIDO F · 1999 to 2019
$30.4M
Center for Natural Product Technologies at UIC (CeNAPT)U41AT008706 · NCCIH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PAULI, GUIDO F · 2015 to 2019
$1.5M
NCCIH NIH HHS P50 AT000155NCCIH NIH HHS U41 AT008706
6 · The paper itself

Abstract

Contemporary bioinformatic and chemoinformatic capabilities hold promise to reshape knowledge management, analysis and interpretation of data in natural products research. Currently, reliance on a disparate set of non-standardized, insular, and specialized databases presents a series of challenges for data access, both within the discipline and for integration and interoperability between related fields. The fundamental elements of exchange are referenced structure-organism pairs that establish relationships between distinct molecular structures and the living organisms from which they were identified. Consolidating and sharing such information via an open platform has strong transformative potential for natural products research and beyond. This is the ultimate goal of the newly established LOTUS initiative, which has now completed the first steps toward the harmonization, curation, validation and open dissemination of 750,000+ referenced structure-organism pairs. LOTUS data is hosted on Wikidata and regularly mirrored on https://lotus.naturalproducts.net. Data sharing within the Wikidata framework broadens data access and interoperability, opening new possibilities for community curation and evolving publication models. Furthermore, embedding LOTUS data into the vast Wikidata knowledge graph will facilitate new biological and chemical insights. The LOTUS initiative represents an important advancement in the design and deployment of a comprehensive and collaborative natural products knowledge base.

Indexed as

Biological ProductsKnowledge ManagementComputational BiologyDatabases, FactualKnowledgeBiological Productscomputational biologyecologyknowledge graphlinked dataLOTUS Initiativenatural productsopen sciencesystems biologyWikidata

Identifiers

PMID35616633
PMCPMC9135406
OpenAlexW4281658583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.